Dexoxadrol

From Wikipedia, the free encyclopedia
Dexoxadrol
Systematic (IUPAC) name
(2S)-2-[(4S)-2,2-di(phenyl)-1,3-dioxolan-4-yl]piperidine
Clinical data
Legal status Legal
Identifiers
CAS number 6495-46-1 N
ATC code None
PubChem CID 3034023
ChemSpider 2298576 YesY
UNII Verifiedfields = changed JY5N9F45AG Verifiedfields = changed N
ChEMBL CHEMBL1165411 YesY
Chemical data
Formula C20H23NO2 
Mol. mass 309.40 g/mol
 N (what is this?)  (verify)

Dexoxadrol (Dioxadrol) is a dissociative anaesthetic drug which has been found to be an NMDA antagonist and produces similar effects to PCP in animals. Dexoxadrol, along with another related drug etoxadrol, were developed as analgesics for use in humans, but development was discontinued after patients reported side effects such as nightmares and hallucinations.[1][2]


References

  1. Sax, M.; Wünsch, B. (2006). "Relationships between the structure of dexoxadrol and etoxadrol analogues and their NMDA receptor affinity". Current Topics in Medicinal Chemistry 6 (7): 723–732. doi:10.2174/156802606776894483. PMID 16719812. 
  2. Aepkers, M.; Wünsch, B. (2005). "Structure-affinity relationship studies of non-competitive NMDA receptor antagonists derived from dexoxadrol and etoxadrol". Bioorganic and Medicinal Chemistry 13 (24): 6836–6849. doi:10.1016/j.bmc.2005.07.030. PMID 16169732. 



This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.